Hydroxyurea therapy in thalassemia

Annals of the New York Academy of Sciences

Volumn 850, Issue , 1998, Pages 120-128

  Loukopoulos, Dimitris ^a   Voskaridou, Ersi ^b   Stamoulakatou, Alexandra ^c   Papassotiriou, Yannis ^c   Kalotychou, Vasiliki ^a   Loutradi, Aphrodite ^b   Cozma, Gabriel ^d   Tsiarta, Heleni ^e   Pavlides, Nikos ^e  

^a UNIVERSITY OF ATHENS   (Greece)

^b Laikon Hospital

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d Cilag AG   (Switzerland)

^e NICOSIA GENERAL HOSPITAL   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA; RECOMBINANT ERYTHROPOIETIN;

ADULT; BETA THALASSEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE; ERYTHROCYTE VOLUME; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MALE; ORAL DRUG ADMINISTRATION; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; WELLBEING;

EID: 0031850655     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10469.x     Document Type: Conference Paper

References (19)

1. LETVIN N. L., D. C. LINCH, P. BEARDSLEY, K. W. MCINTYRE & D. G. NATHAN. 1984. Augmentation of fetal hemoglobin production in anemic monkeys by hydroxyurea. N. Engl. J. Med. 310: 317-323.
2. CHARACHE S., G. J. DOVER, R. D. MOORE, S. ECKERT, S. K. BALLAS, M. KOSHY, P. F. A. MILNER, B. P. ORRINGER, G. J. PHILLIPS, O. S. PLATT & G. H. THOMAS. 1992. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 79: 2555-2565.
3. PLATT, O. S., S. H. ORKIN, G. J. DOVER, G. P. BEARDSLEY, B. MILLER & D. G. NATHAN. 1984. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J. Clin. Invest. 74: 652-656.
4. VEITH, R., R. GALANELLO, TH. PAPAYANNOPOULOU & G. STAMATOYANNOPOULOS. 1995. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N. Engl. J. Med. 313: 1571-1575.
5. DESIMONE, J., P. HELLER, L. HALL & D. ZWIERS. 1982. 5′-Azacytidine stimulates fetal hemoglobin synthesis (HbF) in anemic baboons. Proc. Natl. Acad. Sci. USA 79: 4428-4431.
6. +-thalassemia. N. Engl. J. Med. 307: 1469-1475.
7. CHARACHE S., M. L. TERRIN, R. D. MOORE, G. J. DOVER, F. B. BARTON, S. V. ECKERT, R. P. MAC MAHON, D. R. BONDS & THE INVESTIGATORS OF THE MULTICENTER STUDY OF HYDROXYUREA IN SICKLE CELL DISEASE. 1995. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 332: 1317-1322.
8. VOSKARIDOU E., V. KALOTYCHOU & D. LOUKOPOULOS. 1995. Clinical and laboratory effects of long term administration of hydroxyurea to patients with sickle cell/α-thalassemia. Brit. J. Haematol. 89: 479-484.
9. KONSTANTOPOULOS, K., G. VAGIOPOULOS, R. KANTOUNI, S. LYMBERI, PATRIARCHEAS, D. GEORGAKOPOULOS & P. FESSAS. 1992. A case of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: A putative role for hydroxyurea. Haematologica 77: 352-354.
10. KOLLIA, P., P. KARABABA, K. SINOPOULOU, E. VOSKARIDOU, M. BOUSSIOU, M. PAPADAKIS & D. LOUKOPOULOS. 1992. β-thalassemia mutations and the underlying β gene cluster haplotypes in the Greek population. Gene Geography 6: 59-70.
11. RACHMILEWITZ, E. A., A. GOLDFARB & G. J. DOVER. 1991. Administration of erythropoietin to patients with beta-thalassemia intermedia. Blood 78: 1145-1147.
12. OLIVIERI, N. F., M. H. FRIEDMAN, S. P. PERRINE, G. J. DOVER & B. SHERIDAN. 1992. Trial of recombinant human erythropoietin: Three patients with thalassemia intermedia. Blood 80: 3258-3260.
13. RODGERS, G. P., G. J. DOVER, N. UYESAKA, C. T. NOGUCHI, A. N. SCHECHTER & A. W. NIENHUIS. 1993. Augmentation by erythropoietin of the fetal hemoglobin response to hydroxyurea in sickle cell disease. N. Engl. J. Med. 328: 73-80.
14. FIBACH, E., L. P. BURKE, A. N. SCHECHTER, C. T. NOGUCHI & G. P. RODGERS. 1993. Hydroxyurea increases fetal hemoglobin in cutured erythroid cells derived from normal individuals and patients with sickle cell anemia or β-thalassemia. Blood 81: 1630-1635.
15. KOLLIA, P., M. POLITOU & D. LOUKOPOULOS. 1998. Hydroxyurea and hemin affect both the transcriptional and post-transcriptional mechanisms of some globin genes in human adult erythroid cells. Ann. N.Y. Acad. Sci. 850. This volume.
16. HAJJAR, F. M. & H. A. PEARSON. 1994. Pharmacologic treatment of thalassemia intermedia with hydroxyurea. J. Pediatrics 125: 490-492.
17. FUCHAROEN, S., N. SIRITINARATKUL, P. WINICHAGOON, J. CHAWTHAWORN, SIRIBOON, W. MUANSUP, S. CHAICHAROEN, N. POOOLSUP, B. CHINDAVIJAK, P. POOTRAKUL, A. PIANKIJAGUM, A. N. SCHECHTER & G. P. RODGERS. 1996. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β-thalassemia/hemoglobin E disease. Blood 87: 887-892.
18. ZENG, Y-T., S-Z. HUANG, A-R. REN, Z-H. LU, F-Y. ZENG, A. N. SCHECHTER & G. P. RODGERS. 1995. Hydroxyurea therapy in β-thalassaemia intermedia: Improvement in haematological parametes due to enhanced β-globin synthesis. Brit. J. Haematol. 90: 557-563.
19. WEINFELD, A, B. SWOLIN & J. WESTIN. 1994. Acute leukemia after hydroxyurea therapy in polycythemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications. Eur. J. Haematol. 52: 134-139.